Using hyperinsulinemic euglycemic clamp techniques incorporating the use of stable isotope infusions, studies have identified the liver (with increased glucose production), muscle (with decreased glucose disposal), and adipose tissue (failure of insulin to suppress lipolysis) as important sites of insulin resistance in patients with NAFLD.7 This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.